The invention provides compounds of formula (I) wherein R is −CH3 or −CH2CH3 and pharmaceutically acceptable salts thereof. The compounds of formula (I) are useful in the treatment of diseases or disorders mediated by IKKE, TBK1 and/or SIK2 mechanisms in a subject, for example cancer and inflammatory and tissue repair disorders. The invention also provides uses of the compounds of formula (I) and compositions containing them. (Formula (I)
The present invention relates to novel piperidine derivatives having better cell growth inhibitory a...
The design, synthesis and structure-activity relationships of a novel series of 2,4-diamino-5-cyclop...
The invention provides compounds of formula (I) or a tautomer, stereoisomer, N-oxide, pharmaceutical...
Compounds of the general formula (I) and salts thereof are useful in the treatment of diseases assoc...
The invention provides a compound that is an inhibitor of one or both of TBK1 and IKKe, or a down-re...
The present invention relates to certain 4-(substituted aniline)-2-(substituted piperidin-1-yl)pyrim...
The invention provides novel compounds based on piperazinylpyrimidine derivatives to be used as prot...
This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of...
The present invention concerns a compound of formula (I), in particular as LIMK and/or ROCK kinases ...
A subject of the present invention is a compound having the general formula (I) a pharmaceutically a...
The present invention relates to 4-pyrimidinylamino-benzenesulfonamide derivatives of general formul...
The present invention relates to novel heterocyclic derivatives having general formula (I) and thei...
The invention is directed to certain novel compounds with biphenyl tricyclic quinazoline structure. ...
The present invention refers to 4-amino-substituted pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyr...
The design, synthesis and structure-activity relationships of a novel series of 2,4-diamino-5-cyclop...
The present invention relates to novel piperidine derivatives having better cell growth inhibitory a...
The design, synthesis and structure-activity relationships of a novel series of 2,4-diamino-5-cyclop...
The invention provides compounds of formula (I) or a tautomer, stereoisomer, N-oxide, pharmaceutical...
Compounds of the general formula (I) and salts thereof are useful in the treatment of diseases assoc...
The invention provides a compound that is an inhibitor of one or both of TBK1 and IKKe, or a down-re...
The present invention relates to certain 4-(substituted aniline)-2-(substituted piperidin-1-yl)pyrim...
The invention provides novel compounds based on piperazinylpyrimidine derivatives to be used as prot...
This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of...
The present invention concerns a compound of formula (I), in particular as LIMK and/or ROCK kinases ...
A subject of the present invention is a compound having the general formula (I) a pharmaceutically a...
The present invention relates to 4-pyrimidinylamino-benzenesulfonamide derivatives of general formul...
The present invention relates to novel heterocyclic derivatives having general formula (I) and thei...
The invention is directed to certain novel compounds with biphenyl tricyclic quinazoline structure. ...
The present invention refers to 4-amino-substituted pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyr...
The design, synthesis and structure-activity relationships of a novel series of 2,4-diamino-5-cyclop...
The present invention relates to novel piperidine derivatives having better cell growth inhibitory a...
The design, synthesis and structure-activity relationships of a novel series of 2,4-diamino-5-cyclop...
The invention provides compounds of formula (I) or a tautomer, stereoisomer, N-oxide, pharmaceutical...